Trials of a vaccine that could protect against Covid-19 are to begin in England. Work on the vaccine, developed by clinical teams at the University of Oxford's Jenner Institute and Oxford Vaccine Group, began in January.
Now a study involving up to 510 healthy volunteers between 18 and 55 is to get under way. The UK now joins only the US - with two studies - and China in beginning human trials.
Professor Saul Faust, director of the NIHR Southampton Clinical Research Facility at University Hospital Southampton, said: "There are not currently any licensed vaccines or specific treatments for Covid-19 but vaccines are the most effective way of controlling outbreaks and the international community has stepped up efforts towards developing one. "